# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Geronimo (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI016-SYN
- Date: 2026-08-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Roberta Whitehorse-Lindgren, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week review: therapy, naltrexone, sleep and mood. **S**

## History of present illness

Geronimo returns six weeks after intake, with the interpreter. He has had four sessions of cognitive processing therapy and says the therapist listens and does not push him to speak of what he will not. He drinks on two evenings a week, two drinks each time, and has had no nausea on naltrexone. The nightmares still come about four nights a week and he sleeps four or five hours. He asks whether a medicine could help him sleep and lift the heaviness. Sertraline was explained, with its side effects and the sodium check, and prazosin for nightmares was discussed: he chose sertraline at a low dose and agreed to wait on prazosin because of his fall. **S**

| Element | Detail |
|---|---|
| Therapy | Four of twelve sessions |
| Drinking | Two evenings a week, two drinks each |
| PCL-5 | 46 |
| PHQ-9 | 10, item 9 scored 0 |
| Liver tests | AST 41, ALT 31, GGT 84 U/L |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Nightmares four nights a week; mood heavy; no thoughts of suicide |
| Gastrointestinal | Negative | No nausea or abdominal pain on naltrexone |
| Neurological | Negative | No dizziness on standing |

3 systems reviewed. **S**

## Current medications

- Thiamine 100 mg oral tablet, one tablet daily **S**
- Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicines **S**
- Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium check **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/78 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 66.8 kg; BMI 22.3 kg/m². All vital signs are synthetic.

PCL-5: 46; PHQ-9: 10; AST: 41 U/L (high); ALT: 31 U/L; GGT: 84 U/L (high). All results are synthetic.

## Change since baseline

- PCL-5: 56 at baseline, 46 at this visit **S**
- PHQ-9: 11 at baseline, 10 at this visit **S**
- AST: 58 U/L (high) at baseline, 41 U/L (high) at this visit **S**
- ALT: 36 U/L at baseline, 31 U/L at this visit **S**
- GGT: 112 U/L (high) at baseline, 84 U/L (high) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 132/78 seated and 130/76 standing; pulse 74; weight 66.8 kg |
| Mental status | Calm; more eye contact; mood heavy; no thoughts of suicide or of harming anyone |
| Gait | Steady; Timed Up and Go 12 seconds |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-traumatic stress disorder, chronic** (F43.12). PCL-5 46, from 56: improving, not yet a meaningful change. He chose sertraline, which the VA/DoD guideline recommends, at a low starting dose for his age. Prazosin, which the guideline suggests for nightmares, is not started now because of orthostatic falls risk after his fall; it will be reconsidered with standing blood pressure checks if nightmares persist after therapy and sertraline. Safety reviewed: no thoughts of suicide or self-harm. **S**
   - Sertraline 25 mg each morning.
   - Sodium within two to four weeks, then the dose raised to 50 mg if tolerated.
   - Continue cognitive processing therapy.
2. **Alcohol use disorder, moderate** (F10.20). Drinking much less on naltrexone; liver tests falling. **S**
   - Continue naltrexone and thiamine.
   - PEth and liver tests at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PTSD symptom severity (PCL-5) | Baseline, then every visit during treatment | Completed today | 46, from 56 |
| Self-management | Trauma-focused psychotherapy (cognitive processing therapy), sessions attended | Weekly for twelve sessions | Completed today | Four of twelve sessions attended |
| Survey | Depressive symptoms (PHQ-9) | Baseline, then monthly during active treatment | Completed today | 10, from 11; item 9 scored 0 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; 988 card carried; sertraline dispensed four weeks at a time |
| Self-management | Drinking since the last visit, against his own goal | Every visit | Completed today | Two evenings a week, two drinks each |
| Laboratory | Liver tests (AST, ALT, GGT) on naltrexone | Before starting, at four to six weeks, then every three to six months | Completed today | AST 41, ALT 31, GGT 84 U/L, four weeks on naltrexone |
| Laboratory | PEth, a blood marker of drinking over the past two to four weeks | At baseline and every one to three months during treatment, with consent | Up to date | Due at the next visit |
| Medication safety | Naltrexone safety: opioid use, nausea, wallet card | Every visit | Completed today | No opioid use; no nausea |
| Medication safety | SSRI safety: sodium, bleeding, falls and side effects | Sodium within the first month in older adults; review at each dose change | Ordered | Sertraline 25 mg started today; sodium due in two to four weeks |
| Medication safety | Prazosin for nightmares | When nightmares persist despite first-line treatment | Not indicated | Not started now: orthostatic falls risk in a man of 77 who fell recently; reconsider after therapy and sertraline |
| Examination | Falls and gait (Timed Up and Go), orthostatic blood pressure | At intake and every visit after a fall | Completed today | Timed Up and Go 12 seconds; standing pressure 130/76; no falls |
| Self-management | Traditional healing alongside clinic care, at his choice | Every visit | Completed today | His choice; nothing asked |

## Goal progress

- Sleep most nights with nightmares no more than once a week. In progress; target 2026-10-28. **S**
- Lower PTSD symptoms by a meaningful amount (PCL-5 down at least 10 to 20 points). In progress; target 2026-10-28. **S**
- Drink no more than one drink on any day, and no drinking before riding. In progress; target 2026-10-28. **S**
- No further falls. In progress; target 2026-10-28. **S**

## Medication changes

- Started: Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium check **S**

## Guideline basis

- VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023), United States Department of Veterans Affairs and Department of Defense (synopsis: Ann Intern Med 2024;177(3):363-374)
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994), Indian Health Service
- American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023), American Geriatrics Society (Journal of the American Geriatrics Society)
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force

## Follow-up

- Sodium in two to four weeks. Eleven-week review with PEth and liver tests. Therapy weekly. Call the clinic or 988 at any hour. **S**
- Next scheduled visit 2026-09-23: eleven-week review: therapy progress, sertraline and sodium, drinking and falls. **S**
